Gilde Healthcare
106
35M
66
2.52
26
0.38
31
- Stages of investment
- Areas of investment
Summary
Gilde Healthcare appeared to be the VC, which was created in 1982. The main office of represented VC is situated in the Utrecht. The fund was located in Europe if to be more exact in The Netherlands.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Hospital. Among the most popular portfolio startups of the fund, we may highlight CVRx, Evotec, Agendia.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Gilde Healthcare, startups are often financed by Morgenthaler Ventures, Ysios Capital, QuestMark Partners. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Morgenthaler Ventures, Gimv. In the next rounds fund is usually obtained by Morgenthaler Ventures, Gimv, Novo Holdings.
The overall number of key employees were 14.
Comparing to the other companies, this Gilde Healthcare performs on 9 percentage points more the average number of lead investments. When the investment is from Gilde Healthcare the average startup value is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2018. The top activity for fund was in 2012. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year.
Investments analytics
Analytics
- Total investments
- 106
- Lead investments
- 26
- Exits
- 31
- Rounds per year
- 2.52
- Follow on index
- 0.38
- Investments by industry
- Biotechnology (73)
- Health Care (62)
- Medical Device (40)
- Medical (37)
- Pharmaceutical (23) Show 41 more
- Investments by region
-
- United States (35)
- Netherlands (21)
- Switzerland (5)
- Ireland (5)
- United Kingdom (10) Show 6 more
- Peak activity year
- 2020
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 38M
- Group Appearance index
- 0.87
- Avg. company exit year
- 11
- Avg. multiplicator
- 1.61
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ADCendo | 29 May 2024 | Biotechnology | Early Stage Venture | 18M | Capital Region of Denmark, Copenhagen, Denmark |
| Moximed | 16 Aug 2022 | Biotechnology, Health Care, Medical Device | Late Stage Venture | 40M | United States, California, Hayward |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.